Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1FN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,149
Award facts
- Contract value 100% obligated
- $16,148.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 15, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, procures Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose unit at a ceiling value of $16,148.63. The award is non-set-aside and employs firm fixed-price pricing, with an ultimate completion date of January 16, 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly operating as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally. Trelegy Ellipta is a combination respiratory medication indicated for chronic obstructive pulmonary disease maintenance treatment, reflecting the Defense Logistics Agency's procurement of essential pharmaceutical commodities to support military treatment facilities and veteran healthcare programs. The non-competitive delivery order structure demonstrates the efficiency of the established IDC vehicle in fulfilling routine federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FA1FN?
SPE2DR26FA1FN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FA1FN worth?
The government has obligated $16,149 on SPE2DR26FA1FN.
Is contract SPE2DR26FA1FN an order under another contract?
Yes. SPE2DR26FA1FN is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1FN competed?
The extent of competition for SPE2DR26FA1FN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award